| Product Name | MF | CAS | Details |
|---|
| N-nitroso-vancomycin | Details |
| N-nitroso-varenicline | Details |
| N-nitroso-desmethyl-venlafaxine | Details |
| N-nitroso-vibegron | Details |
| N-nitroso-vilanterol | Details |
| N-nitroso-viloxazine | Details |
| N-nitroso-vortioxetine | Details |
| N-nitroso-desmethyl-zolmitriptan | Details |
| Ixazomib Impurity 7 | Details |
| MLN9708 | C20H23BCl2N2O9 | 1201902-80-8 | Details |
| 2,3,4-TRICHLOROBENZOIC ACID | C7H3Cl3O2 | 50-75-9 | Details |
| 2,3,5-Trichlorobenzoic acid | C7H3Cl3O2 | 50-73-7 | Details |
| 2,4,5-Trichlorobenzoic acid | C7H3Cl3O2 | 50-82-8 | Details |
| Benzamide, 2,5-dichloro-N-[2-[(3-methylbutyl)amino]-2-oxoethyl]- | C14H18Cl2N2O2 | 2872629-73-5 | Details |
| 2,5-dichloro-N,N-dimethylbenzamide | C9H9Cl2NO | 90526-01-5 | Details |
| Boronic acid, B-[(1R)-1-[(2,5-dichlorobenzoyl)amino]-3-methylbutyl]- | C12H16BCl2NO3 | 2806031-79-6 | Details |
| Benzamide, 2,5-dichloro-N-(3-methylbutyl)- | C12H15Cl2NO | 349086-08-4 | Details |
| Benzamide, 2,5-dichloro-N-[2-[(3-methylbutylidene)amino]-2-oxoethyl]- | C14H16Cl2N2O2 | 1429055-05-9 | Details |
| Ixazomib citrate (USAN) | C20H23BCl2N2O9 | 1239908-20-3 | Details |
| Ixazomib Impurity 20 | Details |
| (R,E)-2-methyl-N-(3-methylbutylidene)propane-2-sulfinamide | C9H19NOS | 220315-20-8 | Details |
| NA | Details |
| NA | Details |
| NA | Details |
| NA | Details |
| NA | Details |
| NA | Details |
| Nemonoxacin Impurity 1 | C20H25N3O4 | 378746-65-7 | Details |
| NA | Details |
| NA | Details |
| NA | Details |
| NA | Details |
| NA | Details |
| NA | Details |
| NA | Details |
| NA | Details |
| NA | Details |
| NA | Details |
| (3S,5R)-3-(Boc-aMino)-5-Methylpiperidine | C11H22N2O2 | 1203651-07-3 | Details |
| tert-butyl N-[(3R,5S)-5-methylpiperidin-3-yl]carbamate | C11H22N2O2 | 1270019-92-5 | Details |
| (3R,5R)-3-(Boc-amino)-5- Methylpiperidine | C11H22N2O2 | 1227919-32-5 | Details |
| NA | Details |
| NA | Details |
| NA | Details |
| NA | Details |
| NA | Details |
| NA | Details |
| NA | Details |
| Butanedioicacid,2-hydroxy-,compd.with7-[(3S,5S)-3-amino-5-methyl-1-piperidinyl]-1-cyclopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylicacid | C20H25N3O4.C4H6O5 | 951163-60-3 | Details |
| Pseudomonic acid C | C26H44O8 | 1980-98-8 | Details |
| Pseudomonic Acid D | C26H42O9 | 85248-93-7 | Details |
| PseudoMonic Acid D SodiuM | C26H41NaO9 | 85178-60-5 | Details |
| Mupirocin EP Impurity D | C26H44O9 | 71087-97-3 | Details |
| Mupirocin EP Impurity E | C26H44O9 | 71087-96-2 | Details |
| PseudoMonic Acid F | C24H40O9 | 167842-64-0 | Details |
| Mupirocin EP Impurity I | Details |
| monic acid A | C17H28O7 | 66262-68-8 | Details |
| NA | Details |
| NA | Details |
| 24,25-Dihydroxyfusidic Acid | C31H50O8 | 80445-74-5 | Details |
| NA | Details |
| 3H-Pyrazol-3-one, 2,4-dihydro-4,4-bis(5-hydroxy-3-Methyl- 1-phenyl-1H-pyrazol-4-yl)-5-Methyl-2-phenyl- | C30H26N6O3 | 124009-63-8 | Details |
| Edaravone Impurity 2 | C13H14N2O2 | 852539-02-7 | Details |
| Edaravone Impurity 35 | Details |
| Edaravone Impurity 36 | Details |
| (3S,4R,4aS,7aR)-3-(cyclopropylmethyl)-4a-hydroxy-9-methoxy-3-methyl-7-oxo-2,3,4,4a,5, 6,7,7a-octahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-3-ium bromide | C22H28BrNO4 | 1005410-37-6 | Details |
| MethylltrexoneHoffmanElimitionImpurity | C21H25NO4 | 1005410-47-8 | Details |
| Potassium Clavulanate EP lmpurity M | C8H21ClN2O | 103526-47-2 | Details |
| (1R,2S)-1-(3-(allyloxy)phenyl)-1-hydroxypropan-2-aminium chloride | Details |
| Amlodipine Impurity 82 | Details |
| NA | Details |
| NA | Details |
| NA | Details |
| NA | Details |
| 5-(2-Bromo-1-oxobutyl)-8-hydroxy-2(1H)-quinolinone | C13H12BrNO3 | 59827-93-9 | Details |
| 8-Hydroxyquinoline-N-oxide | C9H7NO2 | 1127-45-3 | Details |
| NA | Details |
| 2-(amino(carboxy)methyl)-5-(((6-hydroxy-2-methyl-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)thio)methyl)-3-nitroso-3,6-dihydro-2H-1,3-thiazine-4-carboxylic acid | Details |
| 5-(acetoxymethyl)-2-(amino(carboxy)methyl)-3-nitroso-3,6-dihydro-2H-1,3-thiazine-4-carboxylic acid | Details |
| N-methylnitrous hydrazide | C4H10N2O | 30533-08-5 | Details |
| Imrecoxib | C21H23NO3S | 395683-14-4 | Details |
| Imrecoxib Impurity 1 | C21H23NO4S | 896729-07-0 | Details |
| Imrecoxib Impurity 6 | C18H18O5S | 1338083-52-5 | Details |
| Imrecoxib Impurity 9 | C18H16O4S | 959003-56-6 | Details |
| Imrecoxib Impurity 92 | Details |
| Imrecoxib Impurity 4 | C9H10O4S | 197240-27-0 | Details |
| Imrecoxib Impurity 5 | C21H23NO3S | 2305368-53-8 | Details |
| Imrecoxib Impurity 7 | Details |
| Omadacycline | C29H40N4O7 | 389139-89-3 | Details |
| Ixazomib Impurity 8 | C9H8Cl2N2O2 | 1378314-08-9 | Details |
| CHEMBRDG-BB 7959525 | C9H7Cl2NO3 | 667403-46-5 | Details |
| Ixazomib Impurity 3 | Details |
| Urea, N-[2-(dimethylamino)ethyl]-N'-ethyl- | C7H17N3O | 62594-29-0 | Details |
| Ixazomib Impurity 5 | Details |
| Ixazomib Impurity 6 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 | ||||